Literature DB >> 10829940

Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

V P Choudhry1, S K Acharya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 10829940     DOI： 10.1007/bf02825110

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  61 in total

1.  Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.

Authors:  S Kaneko; R H Miller; A M Di Bisceglie; S M Feinstone; J H Hoofnagle; R H Purcell
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

2.  Controlled clinical trial of acyclovir in chronic hepatitis B virus infection.

Authors:  G J Alexander; E A Fagan; J E Hegarty; J Yeo; A L Eddleston; R Williams
Journal:  J Med Virol       Date:  1987-01       Impact factor: 2.327

3.  Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis.

Authors:  J Y Yoo; R Howard; J G Waggoner; J H Hoofnagle
Journal:  J Med Virol       Date:  1987-11       Impact factor: 2.327

4.  Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.

Authors:  S Gulati; R K Marwaha; J B Dilawari; U Midha; B N Walia
Journal:  Indian Pediatr       Date:  1992-01       Impact factor: 1.411

5.  Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment.

Authors:  P Karayiannis; S Kanatakis; H C Thomas
Journal:  J Hepatol       Date:  1990-05       Impact factor: 25.083

6.  Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.

Authors:  Y L Lau; C B Chow; A C Lee; K W Ng; W L Lim; C F Chan; S Y Lam; C K Li
Journal:  Bone Marrow Transplant       Date:  1993       Impact factor: 5.483

7.  Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

Authors:  M Shindo; A M Di Bisceglie; L Cheung; J W Shih; K Cristiano; S M Feinstone; J H Hoofnagle
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

8.  Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis.

Authors:  M Resti; C Azzari; M E Rossi; C Vullo; E Zammarchi; A Vierucci
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

9.  Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.

Authors:  M G Clemente; M Congia; M E Lai; F Lilliu; R Lampis; F Frau; M R Frau; G Faa; G Diana; C Dessì
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

10.  Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees.

Authors:  M B Hurie; E E Mast; J P Davis
Journal:  Pediatrics       Date:  1992-02       Impact factor: 7.124
View more
  4 in total

1.  Hepatitis B and C infections in multitransfused thalassemic patients.

Authors:  Ved Prakash Choudhry
Journal:  Indian J Pediatr       Date:  2015-02-12       Impact factor: 1.967

Review 2.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

Review 3.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

Review 4.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.